COST PER RESPONDER OF BIMEKIZUMAB AGAINST IL17A, IL-12/23 AND IL-23 INHIBITORS IN THE TREATMENT OF PSORIATIC ARTHRITIS IN SWEDEN

被引：0
|
作者：
Lyris, N. [1 ]
Geale, K. [2 ,3 ]
Aldven, M. [3 ]
Engstrom, A. [4 ]
Willems, D. [5 ]
机构：
[1] UCB Pharma, Slough, Berks, England
[2] Umea Univ, Dept Publ Hlth & Clin Med, Dermatol & Venerol, Umea, Sweden
[3] Quantify Res, Stockholm, Sweden
[4] UCB Pharm, Stockholm, Sweden
[5] UCB Pharm, Brussels, Belgium
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE649
引用
收藏
页码：S178 / S178
页数：1
相关论文
共 50 条
  • [41] IL12/IL23 Inhibition in the Treatment of Psoriatic Arthritis
    Mahta Mortezavi
    Christopher Ritchlin
    Current Treatment Options in Rheumatology, 2015, 1 (2) : 197 - 209
  • [42] IL-23 and IL-12 responses in activated human T cells retrovirally transduced with IL-23 receptor variants
    de Paus, Roelof A.
    van de Wetering, Diederik
    van Dissel, Jaap T.
    van de Vosse, Esther
    MOLECULAR IMMUNOLOGY, 2008, 45 (15) : 3889 - 3895
  • [43] Serum level of IL-23 and IL-23R polymorphisms in patients with psoriatic arthritis
    Sokolik, Renata
    Gebura, Katarzyna
    Korman, Lucyna
    Wysoczanska, Barbara
    Wiland, Piotr
    Bogunia-Kubik, Katarzyna
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S22 - S22
  • [44] IL-23 and IL-17A, but Not IL-12 and IL-22, Are Required for Optimal Skin Host Defense against Candida albicans
    Kagami, Shinji
    Rizzo, Heather L.
    Kurtz, Stephen E.
    Miller, Lloyd S.
    Blauvelt, Andrew
    JOURNAL OF IMMUNOLOGY, 2010, 185 (09): : 5453 - 5462
  • [45] Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae
    Happel, KI
    Dubin, PJ
    Zheng, MQ
    Ghilardi, N
    Lockhart, C
    Quinton, LJ
    Odden, AR
    Shellito, JE
    Bagby, GJ
    Nelson, S
    Kolls, JK
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (06): : 761 - 769
  • [46] The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review
    Tsiogka, Aikaterini
    Gregoriou, Stamatios
    Stratigos, Alexander
    Soulaidopoulos, Stergios
    Rompoti, Natalia
    Panagakis, Pantelis
    Papoutsaki, Marina
    Kostakis, Panagiotis
    Kontochristopoulos, George
    Tsioufis, Konstantinos
    Campanati, Anna
    Offidani, Annamaria
    Vlachopoulos, Charalambos
    Rigopoulos, Dimitrios
    BIOMEDICINES, 2023, 11 (02)
  • [47] SERUM LEVEL OF IL-23 AND IL-23R POLYMORPHISMS IN PATIENTS WITH PSORIATIC ARTHRITIS
    Sokolik, R.
    Gebura, K.
    Korman, L.
    Wysoczanska, B.
    Wiland, P.
    Bogunia-Kubik, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 610 - 610
  • [48] Use of IL-23 Inhibitors for the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review
    Yang, Kevin
    Oak, Allen S. W.
    Elewski, Boni E.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (02) : 173 - 192
  • [49] Use of IL-23 Inhibitors for the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review
    Kevin Yang
    Allen S. W. Oak
    Boni E. Elewski
    American Journal of Clinical Dermatology, 2021, 22 : 173 - 192
  • [50] Regulation of Antitumor Immune Responses by the IL-12 Family Cytokines, IL-12, IL-23, and IL-27
    Xu, Mingli
    Mizoguchi, Izuru
    Morishima, Noriko
    Chiba, Yukino
    Mizuguchi, Junichiro
    Yoshimoto, Takayuki
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2010,
12345